Scouting out the neighborhood in AIDS-related lymphoma

Blood

Volumn 122, Issue 3, 2013, Pages 306-307

  Dunleavy, Kieron ^a   Bollard, Catherine M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LATENT MEMBRANE PROTEIN 1; ONCOPROTEIN; PREDNISONE; RITUXIMAB; TRANSCRIPTION FACTOR FOXP3; VASCULOTROPIN; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD VESSEL; CD8+ T LYMPHOCYTE; CELL LINEAGE; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; B CELL LYMPHOMA; FEMALE; MALE; NOTE; PATHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; TUMOR MICROENVIRONMENT;

EID: 84884633982     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-06-502591     Document Type: Review

References (17)

1. Liapis K, Clear A, Owen A, et al. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. Blood. 2013;122(3):424-433.
2. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503-511. (Pubitemid 30082188)
3. Aleksic M, Liddy N, Molloy PE, Pumphrey N, Vuidepot A, Chang KM, Jakobsen BK. Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies. Eur J Immunol. 2012;42(12):3174-3179.
4. Li Y, Moysey R, Molloy P, et al. Directed evolution of human T-cell receptor with picomolar affinities by phage display. Nat Biotechnol. 2005;23(3):349-354. (Pubitemid 41094424)
5. Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood. 1997;90(3):1217-1225. (Pubitemid 27314159)
6. Kawamata F, Kamachi H, Einama T, et al. Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer. Int J Oncol. 2012;41(6):2109-2118
7. King CG, Koehli S, Hausmann B, Schmaler M, Zehn D, Palmer E. T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology. Immunity. 2012;37(4): 709-720.
8. Janicki CN, Jenkinson SR, Williams NA, Morgan DJ. Loss of CTL function among high-avidity tumor-specific CD81 T cells following tumor infiltration. Cancer Res. 2008;68(8):2993-3000. (Pubitemid 351556300)
9. Zhu Z, Singh V, Watkins SK, Bronte V, Shoe JL, Feigenbaum L, Hurwitz AA. High-avidity T cells are preferentially tolerized in the tumor microenvironment. Cancer Res. 2013;73(2):595-604.
10. Dunleavy K, Pittaluga S, Czuczman MS, et al. Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood. 2009;113(24):6069-6076.
11. Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med. 2008; 359(22):2313-2323.
12. Murono S, Inoue H, Tanabe T, et al. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA. 2001;98(12):6905-6910. (Pubitemid 32538315)
13. Caccuri F, Giagulli C, Bugatti A, et al. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. Proc Natl Acad Sci USA. 2012;109(36):14580-14585.
14. Bollard CM, Gottschalk S, Leen AM, et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood. 2007;110(8):2838-2845. (Pubitemid 350006936)
15. Bollard CM, Gottschalk S, Helen Huls M, Leen AM, Gee AP, Rooney CM. Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virusassociated lymphoma. Cytotherapy. 2011;13(5):518-522.
16. Ruan J, Hajjar K, Rafii S, Leonard JP. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma. Ann Oncol. 2009;20(3):413-424.
17. Wahl O, Oswald M, Tretzel L, Herres E, Arend J, Efferth T. Inhibition of tumor angiogenesis by antibodies, synthetic small molecules and natural products. Curr Med Chem. 2011;18(21):3136-3155.